Recessive Dystrophic Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Recessive Dystrophic Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating gentamicin therapy for nonsense mutations in Recessive Dystrophic Epidermolysis Bullosa has completed…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Gentamicin for RDEB [Phase 1, Phase 2]
Phase 1/2 trial of gentamicin for Recessive Dystrophic Epidermolysis Bullosa has completed with results posted in 2019.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
Clinical trial update on mesenchymal stromal cells for adults with Recessive Dystrophic Epidermolysis Bullosa (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa [Phase 1]
Phase I trial evaluating isotretinoin in patients with recessive dystrophic epidermolysis bullosa has completed.
-
CLINICAL_TRIALS research · 2014-05-16Clinical Trial Update: Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
This update describes the characteristics of adult patients with recessive dystrophic epidermolysis bullosa.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.